Novartis AG Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (58)

Latest Posts

About This Stock More About This Stock
E A Terrible Thursday Falls On Friday
Article By: Vivian Lewis
Saturday, April 21, 2018 1:14 PM EDT
More follows from a Friday behaving like a Thursday, with 6 big news breaks, including 3 corporate results plus lots of lesser news.
In this article: BLX, CEA, CZZ, DB, GSK, NVS, SLB, FANUF, IVSBF, RNSHF, TCEHY, MELI, AMZN, TEVA Also: BUD, VRGDF
Read
Novartis Beats Earnings And Revenue Estimates In Q1
Article By: Zacks Investment Research
Thursday, April 19, 2018 12:14 PM EDT
Novartis AG reported encouraging results for first-quarter 2018 wherein both earnings and revenues beat estimates driven by strong performance of Cosentyx and Entresto.
In this article: NVS Also: GSK, ONCE, AVXS
Read
Biotechs Bounce Off Bottom On Novartis Deal But Fade Later In The Day
Article By: Rod Raynovich
Monday, April 9, 2018 7:49 PM EDT
Normally this kind of M&A news would be an opportunity to load up on biotechs but technicals are still weak and crosscurrents from economic and macro news create a risk-off sentiment.
In this article: NVS, FBT, AGIO, AVXS Also: IBB, SGMO, XBI, BLUE, ONCE, CLLS, EDIT, NTLA, CRSP
Read
After Former Citron Short Target AveXis Gets Bought, Analyst Asks 'who's Next'
Article By: The Fly
Monday, April 9, 2018 11:25 AM EDT
AveXis shares are surging after the gene therapy researcher announced an agreement to be acquired by Novartis for $218 per share, or $8.7billion in cash. This comes two years after Citron Research made a short call of a AveXis $5 price target.
In this article: NVS, AVXS Also: BMRN, VYGR, BLUE, ONCE, RGNX
Read
E Chinese And Burmese Lobbyists
Article By: Vivian Lewis
Tuesday, April 3, 2018 11:59 PM EDT
Today we have an exotic annual report to cover and lots of news. The goods range from China to India, from Mexico to Sweden, from Qatar to Israel, from Myanmar to Japan, from Switzerland to Britain, plus lots of points in between.
In this article: CEA, SQM, TCEHY, AZRE, SHPG, GSK, NVS, RHHBY, TEVA, MXCHF, CX, ALV, KUBTY, EC, SLB, VOD, FANUY, MAGS, ISL, SGF, GRR, IF, MXE, TEI
Read

PARTNER HEADLINES

Latest Tweets for $NVS

No tweets yet!

$NVS

OncoSec Raising Its Profile In Fight Against Cancer
BreakingBad News 9/6/2017 3:48:05 PM

More good news on the war against #Cancer, thanks. #Novartis also has made great progress against B-cell acute lymphoblastic leukemia: www.talkmarkets.com/.../finally-a-cure-for-cancer $ONCS $NVS

Finally… A Cure for Cancer?
BreakingBad News 9/6/2017 3:30:54 PM

Lot of good news against the war on #Cancer. Also just read this about #OncoSec: www.talkmarkets.com/.../oncosec-raising-its-profile-in-fight-against-cancer $ONCS $NVS

Novartis Receives FDA Approval For An Acute Myeloid Leukemia Drug
Terry Chrisomalis 5/1/2017 12:22:24 AM

Yes it does indeed. #Novartis has been doing very well lately. $NVS

Novartis Receives FDA Approval For An Acute Myeloid Leukemia Drug
Danielle Rogers 4/30/2017 5:29:49 PM

Triple the effectiveness over a placebo looks very promising! $NVS

1 to 5 of 5 comments